Plasma dihydroxyphenylalanine (DOPA) is independent of sympathetic activity in humans.
To clarify the origin of plasma DOPA (3,4-Dihydroxyphenylalanine), the relationship between plasma DOPA and acute or chronic changes in sympathetic activity has been studied. Plasma DOPA and noradrenaline (NA) concentrations were measured by reverse-phase high-performance liquid chromatography with electrochemical detection. Administration of clonidine to healthy men decreased plasma NE markedly compared to no drug. Plasma DOPA decreased slightly but significantly with time, but values were identical after clonidine compared to no drug. Baseline plasma NE concentrations were significantly reduced in diabetic patients with autonomic neuropathy compared to diabetics without neuropathy, whereas baseline plasma DOPA concentrations were similar in the three groups investigated: 6.55 (5.03-7.26, median [interquartile range], n = 8) nmol l-1 in diabetics with neuropathy, 7.41 (5.79-7.97, n = 8) nmol l-1 in diabetics without neuropathy, and 6.85 (5.58-7.36, n = 8) nmol l-1 in controls. No relationship was obtained between baseline values of plasma NE and plasma DOPA. Plasma DOPA did not change in the upright position, whereas plasma NE increased significantly. Our results indicate that plasma DOPA is not related to sympathetic activity and may be of non-neuronal origin.
Eldrup
E
E
Department of Internal Medicine and Endocrinology, Herlev University Hospital, Denmark.
Christensen
N J
NJ
Andreasen
J
J
Hilsted
J
J
D000328:Adult; D000368:Aged; D003000:Clonidine / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000097:blood; D003929:Diabetic Neuropathies / Q000097:blood; D004295:Dihydroxyphenylalanine / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D011187:Posture; D013564:Sympathetic Nervous System / Q000502:physiology*
D004295:Dihydroxyphenylalanine; D003000:Clonidine; D009638:Norepinephrine